NIH awards $3.96 million to develop combination therapies for superbugs

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

Gram-negative bacteria pose a serious threat to global health because they can resist multiple antibiotics, making infections difficult to treat, according to the National Institutes of Health.